Navigation Links
Renaissance Health Publishing, LLC Asks Key Credibility Questions of ConsumerLab.com
Date:12/4/2007

BOCA RATON, Fla., Dec. 4 /PRNewswire/ --ConsumerLab.com, LLC claims to be a leading provider of independent test results and information to help consumers and healthcare professionals evaluate health, wellness, and nutrition products. But Renaissance Health Publishing, LLC -- the makers of Revatrol, a red-wine 100MG resveratrol supplement -- is confused and disappointed as to why a recent study by ConsumerLab.com on red wine supplements analyzed a formulation of Revatrol that has been out-of-date for months.

"Not only did they test an obsolete formulation, but Dr. Tod Cooperman of ConsumerLab.com publicly disparaged our product. He insisted our product name implied that it contained resveratrol, but that according to their analysis it contains very little. Dr. Cooperman's statement was an outright misrepresentation," says James DiGeorgia CEO of Renaissance Health Publishing, LLC.

The truth about Revatrol, which ConsumerLab.com would have determined had it exercised adequate due-diligence and tested the current formulation, is that Revatrol contains:
-- 100MG of Actual Resveratrol

-- 100MG Alpha Lipoic Acid

-- 100MG Acetyl-L-Carnitine

-- 100MG Quercetin

According to Renaissance Health, two weeks ago they called on the for- profit laboratory to remove the information ConsumerLab.com currently portrays for Revatrol from its study, and to retest Revatrol's current product, which has been on the market for more than nine (9) months. ConsumerLab.com instead added a notation saying the formulation tested was discontinued.

In the course of Renaissance Health's investigation into this matter and into ConsumerLab.com, they've posed questions that Dr. Tod Cooperman, M.D., president of ConsumerLab.com, LLC, has simply ignored.

"We believe that any organization claiming or implying to be an independent consumer advocate should have no problem answering the basic and simple questions we've asked," says DiGeorgia.

"Our questions go right to the heart of the matter at hand-credibility," explained DiGeorgia. DiGeorgia says the questions that ConsumerLab.com has ignored are:

***Question 1: Is ConsumerLab.com actually a lab or does the company contract outside labs to conduct product testing?

"How can ConsumerLab.com claim to be independent if it accepts fees, accepts advertising and charges $3,000 to $4,000 for laboratory analysis that can be obtained for $400 to $800 from other reputable testing labs?" asks DiGeorgia. "The very name of the ConsumerLab.com implies that this is a lab, yet when we asked whether ConsumerLab.com is actually a laboratory we have gone ignored for many days."

***Question 2: Will ConsumerLab.com please make public all monies received from all companies and persons connected with any and all products they have tested?

"Shouldn't a company that claims independence be willing to voluntarily open its records and reveal what money it's received and from who?" asks DiGeorgia.

***Question 3: Why is ConsumerLab.com a for-profit company instead of a non-for-profit?

"ConsumerLab.com has subscription sales that should be able to support their business model. Why accept any monies from companies that have products which have been or are going to be tested?" wonders DiGeorgia.

"I think it is intellectually dishonest to claim independence, but still accept monies from the companies whose products they test. Moreover, the media has been accepting ConsumerLab.com's testing results without asking these key questions. It's crazy," concludes DiGeorgia.

For more information on Revatrol and its potent anti-aging benefits, please visit http://www.revatrol.com or call our knowledgeable representatives at 1-866-482-6678.


'/>"/>
SOURCE Renaissance Health Publishing, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. ConsumerLab.com Study On Revatrol NOT Based on Current Formulation - the Revatrol Sample Used Was More Than Nine Months Out-Of-Date, says Renaissance Health Publishing
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Air pollution linked to cardiovascular risk indices in healthy young adults
5. More proof needed of safety and quality of electronic personal health records
6. Health care incentive model offers collaborative approach
7. Loneliness is bad for your health
8. Mailman School of Public Health study examines link between racial discrimination and substance use
9. Green Tea May Brew Up Healthier Skin
10. For Health Info, Women Often Turn to the Web
11. Record Number of Americans Lack Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Dr. ... Board of Dermatology and fellowship trained Mohs and cosmetic surgeon. After extensive dermatology ... Dr. Li completed his internship in internal medicine at the Emory University and ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... now offering treatments for patients with sleep apnea and TMJ disorders. These conditions ... and physical health. Dr. Rassouli provides personalized care to reduce the risk of ...
(Date:1/19/2017)... ... January 19, 2017 , ... Rountree ... planning services to communities throughout eastern Georgia, is embarking on a charity effort ... Heart disease kills more Americans every year than anything else, yet risk factors ...
(Date:1/19/2017)... ... January 19, 2017 , ... Creative messages ... Real Impact contest from Impact Teen Drivers and California Casualty. Entries from students ... , Educational grants totaling $15,000 will be awarded for the best peer-to-peer messages ...
(Date:1/19/2017)... ... , ... The 21st Century Cures Act’s Impact on Medical Devices:, What You ... 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          , What do ... this year? , The passage of the act means devicemakers will be scrambling to ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... -- Accuray Incorporated (Nasdaq: ARAY ) announced ... set the bar for excellence in customer satisfaction. The ... rating among radiation treatment delivery systems in the U.S., ... Briefing™. The most recent ratings trend also shows Accuray ... for 11 of the past 12 quarters. ...
(Date:1/19/2017)... 19, 2017 Shire plc (LSE: ... U.S. Food and Drug Administration (FDA) has acknowledged receipt ... Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine ... once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is ... 20, 2017, the designated Prescription Drug User Fee Act ...
(Date:1/19/2017)... The global  pacemaker market  is expected to reach USD ... Inc. The heightening prevalence of cardiac conditions coupled with the availability of medical ... addition, technological enhancements in these devices are supporting the expansion of this vertical. ... ... Grand View Research Logo ...
Breaking Medicine Technology: